Management of Locally Advanced Gastroesophageal Cancer Still a Multidisciplinary Global Challenge?

被引：16

作者：

Al-Batran, Salah-Eddin ^{[1
]}

Lorenzen, Sylvie ^{[2
]}

机构：

[1] UCT Univ Canc Ctr, Krankenhaus Nordwest, Inst Clin Canc Res, Steinbacher Hohl 2-26, D-60488 Frankfurt, Germany

[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Hematol & Oncol, Ismaninger Str 22, D-81675 Munich, Germany

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 31卷 / 03期

关键词：

Gastroesophageal cancer; Perioperative; Locally advanced; Chemotherapy; RESECTED GASTRIC-CANCER; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; ESOPHAGOGASTRIC ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; 7TH EDITION; SURGERY; MULTICENTER; JUNCTION;

D O I：

10.1016/j.hoc.2017.01.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The outcome of patients with locally advanced, resectable gastric cancer, or adenocarcinoma of the gastroesophageal junction is poor. In clinical trials, multimodality therapy, such as perioperative chemotherapy, preoperative or postoperative chemoradiation, or adjuvant chemotherapy led to significant increments in survival. Therefore, experts agree that patients with stage II or III disease should be offered a multidisciplinary treatment approach. However, patients are treated somewhat differently in the different regions of the world and survival rates remain far from being satisfactory. Efforts to further improve outcome are highly warranted.

引用

页码：441 / +

页数：13

共 42 条

[1] Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Hofheinz, Ralf D. ;

Pauligk, Claudia ;

Kopp, Hans-Georg ;

Haag, Georg Martin ;

Luley, Kim Barbara ;

Meiler, Johannes ;

Homann, Nils ;

Lorenzen, Sylvie ;

Schmalenberg, Harald ;

Probst, Stephan ;

Koenigsmann, Michael ;

Egger, Matthias ;

Prasnikar, Nicole ;

Caca, Karel ;

Trojan, Joerg ;

Martens, Uwe M. ;

Block, Andreas ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Clemens, Michael ;

Illerhaus, Gerald ;

Zirlik, Katja ;

Behringer, Dirk M. ;

Schmiegel, Wolff ;

Pohl, Michael ;

Heike, Michael ;

Ronellenfitsch, Ulrich ;

Schuler, Martin ;

Bechstein, Wolf O. ;

Koenigsrainer, Alfred ;

Gaiser, Timo ;

Schirmacher, Peter ;

Hozaeel, Wael ;

Reichart, Alexander ;

Goetze, Thorsten O. ;

Sievert, Mark ;

Jaeger, Elke ;

Moenig, Stefan ;

Tannapfel, Andrea .

LANCET ONCOLOGY, 2016, 17 (12) :1697-1708

[2] Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072) [J].

Alderson, Derek ;

Langley, Ruth E. ;

Nankivell, Matthew Guy ;

Blazeby, Jane M. ;

Griffin, Michael ;

Crellin, Adrian ;

Grabsch, Heike I. ;

Okines, Alicia Frances Clare ;

Goldstein, Cindy ;

Falk, Stephen ;

Thompson, Joyce ;

Krysztopik, Richard ;

Coxon, Fareeda Y. ;

Pritchard, Susan ;

Langer, Rupert ;

Stenning, Sally Patricia ;

Cunningham, David .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[3]

Bang YJ, 2010, LANCET, V376, P1302

[4] Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy [J].

Becker, K ;

Mueller, JD ;

Schulmacher, C ;

Ott, K ;

Fink, U ;

Busch, R ;

Böttcher, K ;

Siewert, JR ;

Höfler, H .

CANCER, 2003, 98 (07) :1521-1530

[5] Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries [J].

Botterweck, AAM ;

Schouten, LJ ;

Volovics, A ;

Dorant, E ;

van den Brandt, PA .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (04) :645-654

[6] Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [J].

Cascinu, Stefano ;

Labianca, Roberto ;

Barone, Carlo ;

Santoro, Armando ;

Carnaghi, Carlo ;

Cassano, Alessandra ;

Beretta, Giordano D. ;

Catalano, Vincenzo ;

Bertetto, Oscar ;

Barni, Sandro ;

Frontini, Luciano ;

Aitini, Enrico ;

Rota, Silvia ;

Torri, Valter ;

Floriani, Irene .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (08) :601-607

[7] Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data [J].

Chou, I ;

Norman, AR ;

Cunningham, D ;

Waters, JS ;

Oates, J ;

Ross, PJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2395-2403

[8]

Cunningham D, 2017, LANCET ONCOL

[9] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].

Cunningham, David ;

Allum, William H. ;

Stenning, Sally P. ;

Thompson, Jeremy N. ;

Van de Velde, Cornelis J. H. ;

Nicolson, Marianne ;

Scarffe, J. Howard ;

Lofts, Fiona J. ;

Falk, Stephen J. ;

Iveson, Timothy J. ;

Smith, David B. ;

Langley, Ruth E. ;

Verma, Monica ;

Weeden, Simon ;

Chua, Yu Jo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20

[10] Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) [J].

De Vita, F. ;

Giuliani, F. ;

Orditura, M. ;

Maiello, E. ;

Galizia, G. ;

Di Martino, N. ;

Montemurro, F. ;

Carteni, G. ;

Manzione, L. ;

Romito, S. ;

Gebbia, V. ;

Ciardiello, F. ;

Catalano, G. ;

Colucci, G. .

ANNALS OF ONCOLOGY, 2007, 18 (08) :1354-1358

← 1 2 3 4 5 →